Rigel to Present at the Jefferies Global Healthcare Conference

Rhea-AI Summary

Rigel Pharmaceuticals (Nasdaq: RIGL), a commercial stage biotechnology company specializing in hematologic disorders and cancer treatments, has announced its participation in the upcoming Jefferies Global Healthcare Conference. CEO Raul Rodriguez will deliver a company overview on June 4, 2025, at 12:50 p.m. ET in New York. The presentation will be accessible via live webcast through Rigel's Investor Relations website.

Founded in 1996 and headquartered in South San Francisco, Rigel focuses on developing novel therapies for patients with blood disorders and cancer. Interested parties can access the presentation through www.rigel.com.

News Market Reaction

-2.19%

1 alert

-2.19% News Effect

On the day this news was published, RIGL declined 2.19%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SOUTH SAN FRANCISCO, Calif., May 28, 2025 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that Raul Rodriguez, the company's president and CEO, will present a company overview at the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025 at 12:50 p.m. ET in New York, NY.

To access the live webcast or archived recording, visit the Investor Relations section of the company's website at www.rigel.com. Please connect to Rigel's website prior to the start of the live webcast to allow for any software downloads.

About Rigel
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the Company's marketed products and pipeline of potential products, visit www.rigel.com.

Contact for Investors & Media:
Investors: 
Rigel Pharmaceuticals, Inc. 
650.624.1232 
ir@rigel.com

Media:
David Rosen 
Argot Partners 
646.461.6387
david.rosen@argotpartners.com 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/rigel-to-present-at-the-jefferies-global-healthcare-conference-302466594.html

SOURCE Rigel Pharmaceuticals, Inc.

FAQ

When is Rigel Pharmaceuticals (RIGL) presenting at the Jefferies Global Healthcare Conference 2025?

Rigel Pharmaceuticals (RIGL) will present at the Jefferies Global Healthcare Conference on Wednesday, June 4, 2025, at 12:50 p.m. ET in New York.

Who will be presenting for Rigel Pharmaceuticals at the Jefferies Healthcare Conference?

Raul Rodriguez, Rigel's president and CEO, will present the company overview at the conference.

How can investors access Rigel's presentation at the Jefferies Conference?

Investors can access the live webcast or archived recording through the Investor Relations section of Rigel's website at www.rigel.com.

What is Rigel Pharmaceuticals' (RIGL) main business focus?

Rigel Pharmaceuticals is a commercial stage biotechnology company focused on developing novel therapies for hematologic disorders and cancer.